Balyasny Asset Management L.P.

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1218710 Chicago, IL

Position in XENE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$13,601,575

+$9,820,560 QoQ

Shares Held

233,905

+177.3% QoQ

Ownership

0.242%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. XENE ranks #47 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	2,779,445	$146,532,340
2	ERAS	Erasca, Inc.	5,143,985	$83,229,677
3	TNGX	Tango Therapeutics, Inc.	3,826,659	$80,053,706
4	APLS	Apellis Pharmaceuticals, Inc.	1,917,501	$77,141,065
5	BMRN	Biomarin Pharmaceutical Inc	1,362,752	$76,981,860
6	CYTK	Cytokinetics Inc	992,545	$65,418,640
7	DAWN	Day One Biopharmaceuticals, Inc.	2,625,235	$56,285,038
8	FOLD	AMICUS THERAPEUTICS, INC.	3,827,513	$55,345,837

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,601,575	233,905	+177.3%	Shares	Sole	2026-05-15
2025-12-31	$3,781,015	84,360	-73.8%	Shares	Sole	2026-02-17
2025-09-30	$12,946,608	322,456	+368.2%	Shares	Sole	2025-11-14
2025-06-30	$2,155,599	68,869	-74.2%	Shares	Sole	2025-08-14
2025-03-31	$8,962,614	267,142	+44.7%	Shares	Sole	2025-05-15
2024-12-31	$7,235,536	184,580	+119.2%	Shares	Sole	2025-02-14
2024-09-30	$3,314,875	84,198	-63.9%	Shares	Sole	2024-11-14
2024-06-30	$9,097,731	233,335	+15.9%	Shares	Sole	2024-08-14
2024-03-31	$8,664,845	201,274	+1169.8%	Shares	Sole	2024-05-13
2023-12-31	$730,097	15,851	-90.3%	Shares	Sole	2024-02-14
2022-12-31	$6,420,307	162,828	+10.5%	Shares	Sole	2023-02-14
2022-09-30	$5,319,514	147,355	—	Shares	Other	2022-11-15
No filing history on record for this holder in this stock.